Cannabigerol - a new milestone in the cannabinoid medicine

Cannabigerol - obscure hemp component having no psychoactive properties, the investigation has shown to be effective in the treatment of glaucoma, multiple sclerosis, and skin diseases. Despite this, varieties containing cannabigerol extremely rare in the market of medical cannabis. There is a way to obtain a variety with a high content of this rare but useful cannabinoid?

All known active ingredients of cannabis come from cannabigerol (CBG) - enzymes with trichomes plants convert the substance into new compounds containing tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabichromene (CBC). Since the substance is a chemical precursor of the new compounds, it remains on the flowering plants in very small quantities. Early harvest does not necessarily mean that a manufacturer of agricultural plants with a high content of KBG. Scientists-botanists believe that the material almost immediately after his release turns into a different cannabinoid compounds.

Medical users of psychoactive hemp can easily find on the market of a plant variety, contain large amounts of THC and CBD, but can you find in stores varieties containing KBG? These varieties are extremely rare, but they exist.

Some European varieties of hemp, which have a high content of CBD, in the course of a certain genetic mutation that makes them "CDB forming gene" inactive, begin to accumulate at flowering KBG instead CBD connection. Botanists believe that this is a recessive trait hemp, but because of it, people can get a variety of hemp, with which you can produce in sufficient quantities KBG.

It is obvious that in the breeding of new varieties go away for a while, but in the end, thanks to the efforts of breeders, a variety cannabigerol become as widespread in the medical market, as the varieties containing CBD. Further hybridization of varieties of hemp will allow physicians and consumers get a brand new medical class, with the properties, which had never before even dreamed of.